MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Sensitivity and Specificity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Semaphorins < Sensitivity and Specificity < Sensory Receptor Cells  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000702 (2018) Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni]Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
000970 (2017) Fabrice Cognasse [France] ; Olivier Garraud [France] ; Hubert Marotte [France]Unlike tocilizumab, etanercept slightly increases experimental thrombin-induced aggregation in healthy individuals.
000A70 (2017) Muznay N. Khawaja [États-Unis] ; Martin J. Bergman [États-Unis] ; Jeffrey Yourish [États-Unis] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Edward Keystone [Canada]Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
000B67 (2017) Laurence S C. Lok [Royaume-Uni] ; Neda Farahi [Royaume-Uni] ; Jatinder K. Juss [Royaume-Uni] ; Chrystalla Loutsios [Royaume-Uni] ; Chandra K. Solanki [Royaume-Uni] ; Adrien M. Peters [Royaume-Uni] ; Francis Donaldson [Royaume-Uni] ; Benjamin Porter-Brown [Royaume-Uni] ; Edwin R. Chilvers [Royaume-Uni]Effects of tocilizumab on neutrophil function and kinetics.
000E32 (2016) Seiji Nakamura [Japon] ; Katsuya Suzuki [Japon] ; Hiroshi Iijima [Japon] ; Yuko Hata [Japon] ; Chun Ren Lim [Japon] ; Yohei Ishizawa [Japon] ; Hideto Kameda [Japon] ; Koichi Amano [Japon] ; Kenichi Matsubara [Japon] ; Ryo Matoba [Japon] ; Tsutomu Takeuchi [Japon]Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study.
001573 (2013) Jeffrey R. Curtis [États-Unis] ; Fenglong Xie ; Rui Chen ; Lang Chen ; Meredith L. Kilgore ; James D. Lewis ; Huifeng Yun ; Jie Zhang ; Nicole C. Wright ; Elizabeth DelzellIdentifying newly approved medications in Medicare claims data: a case study using tocilizumab.
001604 (2013) Kei Ikeda [Japon] ; Daiki Nakagomi ; Yoshie Sanayama ; Mieko Yamagata ; Ayako Okubo ; Taro Iwamoto ; Hirotoshi Kawashima ; Kentaro Takahashi ; Hiroshi NakajimaCorrelation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
001618 (2013) Syed Farhan Bari [Royaume-Uni] ; Afsha Khan ; Tom LawsonC reactive protein may not be reliable as a marker of severe bacterial infection in patients receiving tocilizumab.
001B07 (2009) Kay Stubenrauch [Allemagne] ; Uwe Wessels ; Rudolf Vogel ; Julia SchleypenEvaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards.
001D49 (????) Ulrich Grosse [Allemagne] ; Jörg Henes ; Gerd Grözinger ; Ina Kötter ; Petros Martirosian ; Frank Eibofner ; Fritz Schick ; Marius HorgerAnatomic-functional (perfusion-based) magnetic resonance imaging follow-up in patients with rheumatoid arthritis treated with anti-interleukin 6 antibodies: a comparison with clinical scores and serologic data.
001D81 (????) Federico Navarro Sarabia [Espagne] ; Francisco J. Blanco ; José Ma Álvaro Gracia ; Juan A. García Meijide ; José Luis Poveda ; Darío Rubio-Rodríguez ; Carlos Rubio-Terrés[Economic evaluation of rheumathoid arthritis monotherapy with tocilizumab and adalimumab].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Sensitivity and Specificity" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Sensitivity and Specificity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Sensitivity and Specificity
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021